

College of Science and Mathematics
9 achievements
Amirikia, K., Mills, P., Bush, J., & Newman, L.
(2011).
Higher population-based incidence rates of triple-negative breast cancer among young African-American women.
Cancer. 117(12),
2747-2753.
![]() |
Morshedian, S., Contreras, C., Hamud, W., Dhakal, B., Khanal, B., & Bush, J.
(2011).
Anti-angiogenic effects of zoledronic acid on osteotropic breast cancer cells.
Presented at
Experimental Biology Meeting, Washington, DC. |
Hale, J., Yamamoto, F., & Bush, J.
(2010).
Proteomic evaluation of pesticide-resistant breast cancer cell lines.
Presented at
Experimental Biology Meeting, Anaheim, CA. |
Morshedian, S., Contreras, C., & Bush, J.
(2010).
Zoledronic acid (Zometa®) preferentially induces cell death in a bone-metastasizing breast cancer cell line.
Presented at
Special Conference of the American Association of Cancer Research, San Diego, CA. |
Morshedian, S., Contreras, C., & Bush, J.
(2010).
Zoledronic acid increases anti-angiogenic factors in an osteotropic breast cancer cell line.
Presented at
Experimental Biology Meeting, Anaheim, CA. |
Piestrup, N., Liu, J., & Bush, J.
(2010).
Development of Protocols for Enrichment of Specific Endocytic Vesicles Involved in β3 Integrin Recycling in a Cell Culture Model.
Presented at
31st Annual Central California Research Symposium. |
Carillo, B., Villalvazo, A., Nitido, A., Ritchey, J., & Bush, J.
(2009).
Multi-drug resistant ovarian cancer cells are less susceptible to orlistat-induced cell death.
Presented at
2nd Cancer Health Disparities–Minorities in Cancer Research, Carefree, AZ. |
Chu, R., Miller, S., & Bush, J.
(2009).
Secretome Analyses from Staged Pancreatic Cancer Cell Lines.
Presented at
5th US Human Proteome Organization (USHUPO), San Diego, CA. |